Action on WHO’s India Biotech, ban on supply of covaxin vaccine

Hyderabad-based Bharat Biotech’s international supply of covaxin has been banned by the World Health Organization (WHO).

WHO suspends supply of India Biotech vaccine This decision has not been made due to the quality of the vaccine The country which has supplied it can take action against this.

Hyderabad-based Bharat Biotech’s international supply of covaxin has been banned by the World Health Organization (WHO). The WHO has told the company that the company’s Good Manufacturing Practice (GMP) is lacking. Good manufacturing practice means in the sense of plant equipment. However, he did not comment on the safety or effectiveness of the vaccine. Covaxin, on the other hand, issued a statement on Sunday following the suspension.The company said the WHO suspension would not affect the safety and effectiveness of the vaccine.

The WHO team inspected Bharat Biotech’s plant from March 14 to March 22, 2022. Following this, he announced the suspension of Covaxin. Covaxin is being supplied to many poor countries. On Saturday, the WHO said that countries receiving the vaccine could take appropriate action against the vaccine.

Constantly improving: Bharat Biotech Following the WHO’s decision, the vaccine maker said on Sunday that the company was “slowing down” production of covaxin for optimization. The company will now focus on maintenance related facilities and other activities. He said that due to the health crisis in the country caused by Covid-19, Bharat Biotech had continuously produced vaccines last year.All arrangements were made from the plant for this, but some equipment was not available during the epidemic. Even after this we have never compromised with quality. “We are constantly improving and upgrading the plant to increase production of covaxin and meet global requirements,” the company said.

The WHO also agreed – safety and effectiveness are not an issue WHO said – WHO has confirmed suspension of supply of COVAXIN manufactured by India (Biotech) by UN procurement agencies. He recommended that countries receiving the vaccine take appropriate action. However, the UN body has clarified that there is no problem regarding the safety and effectiveness of the vaccine.